Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc. Stock

24.19P/E
€14.44BMarket capitalisation
US$6.74Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Neurocrine Biosciences Inc. is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Neurocrine Biosciences Inc. stock.

Market capitalisation
€14.44B
P/E
24.19
P/B
3.72
P/S
4.59
P/CF
15.60
Issued shares 101M Units

Return

Here you can see the performance of the Neurocrine Biosciences Inc. stock.

PeriodPerfor­mance
1 Week-9.00 %
1 Month+17.31 %
3 Months-18.64 %
6 Months+9.36 %
1 Year+3.16 %
YTD+0.12 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Neurocrine Biosciences Inc. share.

DateRatio
No data available.

Which ETF contains the Neurocrine Biosciences Inc. stock?

The Neurocrine Biosciences Inc. stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Neurocrine Biosciences Inc. has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Neurocrine Biosciences Inc. stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.